Influenza Diagnostics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Influenza Diagnostics Market is predicted to grow at a CAGR of 6% during the forecasting period market is expected to grow from $4.0 billion in 2020 to a value of $5.8 billion in 2027.

The diagnosis of influenza consists of several flu tests used to detect the influenza virus in a sample of the respiratory tract. The most common is the “rapid influenza diagnostic test”. Rapid influenza diagnostic tests work by detecting the part of the virus (antigen) that stimulates the immune response.

Market Segments

By Type of Flu

• Type A Flu
• Type B Flu
• Type C Flu

By Test Type

• Traditional Diagnostic Tests
• Molecular Diagnostic Tests

By End-User

• Hospitals & Clinical Laboratories
• Point-of-Care Testing

Key Players

The major companies in the influenza diagnostic market include Hoffmann-La Roche AG (Switzerland), Quidel Corporation (US), Thermo Fisher Scientific Inc. (US), Abbott Laboratories, Inc. (US), and Hologic Inc. (US).

Scope of the Report

The research study analyzes the global Influenza Diagnostics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Influenza Diagnostics Market Report

1. What was the Influenza Diagnostics Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Influenza Diagnostics Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Influenza Diagnostics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.